68 related articles for article (PubMed ID: 2578550)
21. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
22. A subset of type-specific epitopes map in the amino terminus of herpes simplex virus type 1 glycoprotein B.
Kousoulas K; Arsenakis M; Pereira L
J Gen Virol; 1989 Mar; 70 ( Pt 3)():735-41. PubMed ID: 2471797
[TBL] [Abstract][Full Text] [Related]
23. Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase.
Preston VG; Palfreyman JW; Dutia BM
J Gen Virol; 1984 Sep; 65 ( Pt 9)():1457-66. PubMed ID: 6088678
[TBL] [Abstract][Full Text] [Related]
24. Herpes simplex virus 1 alkaline nuclease is required for efficient egress of capsids from the nucleus.
Shao L; Rapp LM; Weller SK
Virology; 1993 Sep; 196(1):146-62. PubMed ID: 8395111
[TBL] [Abstract][Full Text] [Related]
25. Identification and typing of herpes simplex virus by enzyme immunoassay with monoclonal antibodies.
Frame B; Mahony JB; Balachandran N; Rawls WE; Chernesky MA
J Clin Microbiol; 1984 Aug; 20(2):162-6. PubMed ID: 6092415
[TBL] [Abstract][Full Text] [Related]
26. Studies on DNA topoisomerases I and II in herpes simplex virus type 2-infected cells.
Bapat AR; Han FS; Liu ZC; Zhou BS; Cheng YC
J Gen Virol; 1987 Aug; 68 ( Pt 8)():2231-7. PubMed ID: 3039049
[TBL] [Abstract][Full Text] [Related]
27. Purification and characterization of the protein kinase encoded by the UL13 gene of herpes simplex virus type 2.
Daikoku T; Shibata S; Goshima F; Oshima S; Tsurumi T; Yamada H; Yamashita Y; Nishiyama Y
Virology; 1997 Aug; 235(1):82-93. PubMed ID: 9300039
[TBL] [Abstract][Full Text] [Related]
28. Physical mapping of herpes simplex virus-coded functions and polypeptides by marker rescue and analysis of HSV-1/HSV-2 intertypic recombinants.
Wilkie NM; Stow ND; Marsden HS; Preston V; Cortini R; Timbury MC; Subak-Sharpe JH
IARC Sci Publ (1971); 1978; (24 Pt 1):11-31. PubMed ID: 221322
[TBL] [Abstract][Full Text] [Related]
29. The herpes simplex virus type 1 alkaline nuclease is not essential for viral DNA synthesis: isolation and characterization of a lacZ insertion mutant.
Weller SK; Seghatoleslami MR; Shao L; Rowse D; Carmichael EP
J Gen Virol; 1990 Dec; 71 ( Pt 12)():2941-52. PubMed ID: 2177086
[TBL] [Abstract][Full Text] [Related]
30. Selective induction of discrete epitopes of herpes simplex virus type 1-specified glycoprotein C by interference with terminal steps in glycosylation.
Olofsson S; Sjöblom I; Glorioso JC; Jeansson S; Datema R
J Gen Virol; 1991 Aug; 72 ( Pt 8)():1959-65. PubMed ID: 1714943
[TBL] [Abstract][Full Text] [Related]
31. Physical mapping of temperature-sensitive mutations of herpes simplex virus type 2 by marker rescue.
Chartrand P; Wilkie NM; Timbury MC
J Gen Virol; 1981 Jan; 52(Pt 1):121-33. PubMed ID: 6267168
[TBL] [Abstract][Full Text] [Related]
32. Glycoproteins with type common and type specific antigenic sites excreted from cells infected with herpes simplex virus types 1 and 2.
Randall RE; Killington RA; Watson DH
J Gen Virol; 1980 Jun; 48(Pt 2):297-310. PubMed ID: 6156995
[TBL] [Abstract][Full Text] [Related]
33. Herpes simplex virus-induced ribonucleotide reductase: development of antibodies specific for the enzyme.
Huszar D; Beharry S; Bacchetti S
J Gen Virol; 1983 Jun; 64 (Pt 6)():1327-35. PubMed ID: 6304235
[TBL] [Abstract][Full Text] [Related]
34. Identification of infected cell-specific monoclonal antibodies and their role in host resistance to ocular herpes simplex virus type 1 infection.
Rector JT; Lausch RN; Oakes JE
J Gen Virol; 1984 Mar; 65 ( Pt 3)():657-61. PubMed ID: 6199458
[TBL] [Abstract][Full Text] [Related]
35. The product of a 1.9-kb mRNA which overlaps the HSV-1 alkaline nuclease gene (UL12) cannot relieve the growth defects of a null mutant.
Martinez R; Shao L; Bronstein JC; Weber PC; Weller SK
Virology; 1996 Jan; 215(2):152-64. PubMed ID: 8560762
[TBL] [Abstract][Full Text] [Related]
36. Production of antibodies of predetermined specificity against herpes simplex virus DNA polymerase and their use in characterization of the enzyme.
Thomas MS; Banks LM; Purifoy DJ; Powell KL
J Virol; 1988 May; 62(5):1550-7. PubMed ID: 2833607
[TBL] [Abstract][Full Text] [Related]
37. The deoxyribonuclease induced after infection of KB cells by herpes simplex virus type 1 or type 2. I. Purification and characterization of the enzyme.
Hoffmann PJ; Cheng YC
J Biol Chem; 1978 May; 253(10):3557-62. PubMed ID: 206546
[TBL] [Abstract][Full Text] [Related]
38. Immunological distinction between the possible origins of enzymatic activity in a polypeptide fragment of staphylococcal nuclease.
Sachs DH; Schechter AN; Eastlake A; Anfinsen CB
Nature; 1974 Sep; 251(5472):242-4. PubMed ID: 4138651
[No Abstract] [Full Text] [Related]
39. Identification of a phosphoprotein in the nuclear matrix by monoclonal antibodies.
Halikowski MJ; Liew CC
Biochem J; 1987 Feb; 241(3):693-7. PubMed ID: 2439066
[TBL] [Abstract][Full Text] [Related]
40. "Non-Essential" Proteins of HSV-1 with Essential Roles In Vivo: A Comprehensive Review.
Dogrammatzis C; Waisner H; Kalamvoki M
Viruses; 2020 Dec; 13(1):. PubMed ID: 33374862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
